Jason Hope Comments on Longevity Research

Stem cells have had mixed reviews from people as business leader Jason Hope explains. He says there are people who can’t say enough good things about what stem cells are doing to cure diseases that were not treatable before. Other people see stem cells as a disaster waiting to happen. Like the creation of more cancer 


For almost a quarter of a century, lab technicians have been gathering embryonic stem cells and successfully growing parent cells. Jason Hope is very supportive of the work that SENS and other laboratories are doing with stem cell research on anti-aging that will make the senior years more enjoyable because in the future, aging diseases will be more treatable. 


Unfortunately, stem cell research for anti-aging is not advanced enough to promote selling on the medical market today. Scientists are conducting studies that are working to find better treatments for such senior-related diseases as Alzheimer’s, heart disease, Parkinson’s Disease strokes, and more. As Jason Hope relates, scientists are experimenting with growing blood cells from matching donors, which can eventually help patients overcome various blood diseases. 

Jason Hope: A Futurologist Mastermind

Jason Hope believes that the scientists should be commended for utilizing stem cells in anti-aging experiments. Not enough research has been done to market anti-aging stem cells in the medical marketplace. Eventually, enough research will be done to enable science to come forth with the maximum benefits the anti-aging treatments can provide senior citizens of the future. 

Jason Hope is using his good fortune as an entrepreneur to finance, which aims to enhance the quality of life long-term rather than finding treatment to aid symptoms of the disease’s progress. As an activist investor, he is aware of the potential roadblocks and fears that most people have about the unknown outcome of stem cell anti-aging treatments. Some of the stem cell treatments for diseases that include Parkinson’s Disease are in clinical trials. The future of senior life without the diseases that go with it might be closer than you think